Literature DB >> 3312133

Zinc deficiency in anorexia nervosa.

R L Katz1, C L Keen, I F Litt, L S Hurley, K M Kellams-Harrison, L J Glader.   

Abstract

Adolescents with anorexia nervosa were evaluated for clinical and biochemical evidence of zinc deficiency. To assess whether these patients would benefit from zinc supplementation, a double-blind, randomized, controlled trial was conducted. The mean zinc intake of the anorexic group calculated on the basis of three-day dietary records was 7.7 +/- 5.2 mg/day, which is significantly below the recommended daily allowance of 15 mg for adolescents (p less than 0.001). The mean urinary zinc excretion in the anorexic group was 257.1 +/- 212.7 micrograms/24 hours compared to 749.9 +/- 897.8 micrograms/24 hours in the control group (p less than 0.005). This result suggests that the zinc status of anorexia nervosa patients may be compromised due to an inadequate zinc intake. Zinc supplementation (50 mg elemental zinc/day) was followed by a decrease in the level of depression and anxiety as assessed by the Zung Depression Scale (p less than 0.05) and the State-Trait Anxiety Inventory (p less than 0.05), respectively. Our data suggest that individuals with anorexia nervosa may be at risk for zinc deficiency and may respond favorably after zinc supplementation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312133     DOI: 10.1016/0197-0070(87)90227-0

Source DB:  PubMed          Journal:  J Adolesc Health Care        ISSN: 0197-0070


  16 in total

Review 1.  Zinc supplementation in the treatment of anorexia nervosa.

Authors:  J C Su; C L Birmingham
Journal:  Eat Weight Disord       Date:  2002-03       Impact factor: 4.652

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Reliability of the AccuSens Taste Kit(c) in patients with eating disorders.

Authors:  C Laird Birmingham; A Wong-Crowe; J Hlynsky; M Gao
Journal:  Eat Weight Disord       Date:  2005-06       Impact factor: 4.652

4.  Zinc gluconate toxicity in wild-type vs. MT1/2-deficient mice.

Authors:  Heidi Hsieh; Michael C Horwath; Mary Beth Genter
Journal:  Neurotoxicology       Date:  2016-12-12       Impact factor: 4.294

Review 5.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 6.  Eating disorders in children and adolescents: pharmacological therapies.

Authors:  L A Kotler; B T Walsh
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 7.  Detection, evaluation, and treatment of eating disorders the role of the primary care physician.

Authors:  J M Walsh; M E Wheat; K Freund
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

Review 8.  Role of zinc in maternal and child mental health.

Authors:  Ann M DiGirolamo; Manuel Ramirez-Zea
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

Review 9.  The evidence linking zinc deficiency with children's cognitive and motor functioning.

Authors:  Maureen M Black
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

10.  Anorexia nervosa responding to zinc supplementation: a case report.

Authors:  H Yamaguchi; Y Arita; Y Hara; T Kimura; H Nawata
Journal:  Gastroenterol Jpn       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.